<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39338220</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>11</Day></PubDate></JournalIssue><Title>Journal of personalized medicine</Title><ISOAbbreviation>J Pers Med</ISOAbbreviation></Journal><ArticleTitle>Assessing the Utility of Prediction Scores PAINT, ISARIC4C, CHIS, and COVID-GRAM at Admission and Seven Days after Symptom Onset for COVID-19 Mortality.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">966</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm14090966</ELocationID><Abstract><AbstractText>The COVID-19 pandemic underscores the need for accurate prognostic tools to predict patient outcomes. This study evaluates the effectiveness of four prominent COVID-19 prediction scores-PAINT, ISARIC4C, CHIS, and COVID-GRAM-at two critical time points: at admission and seven days post-symptom onset, to assess their utility in predicting mortality among hospitalized patients. Conducted at the Clinical Emergency Hospital Pius Brînzeu in Timișoara, this retrospective analysis included adult patients hospitalized with confirmed SARS-CoV-2 infection. Eligible patients had complete data for the scores at both time points. Statistical analysis involved ROC curves and logistic regression to assess the scores' predictive accuracy for mortality. The study included 215 patients, split into 139 survivors and 76 non-survivors. At admission, the PAINT, ISARIC4C, CHIS, and COVID-GRAM scores significantly differentiated between the survival outcomes (<i>p</i> &lt; 0.0001). The best cutoff values at admission were 6.26 for PAINT, 7.95 for ISARIC4C, 5.58 for CHIS, and 0.63 for COVID-GRAM, corresponding to sensitivities of 85.47%, 80.56%, 88.89%, and 83.33% and specificities of 77.34%, 82.12%, 75.01%, and 78.45%, respectively. By day seven, the cutoff values increased, indicating deteriorating conditions in patients who eventually succumbed to the virus. The hazard ratios at admission for exceeding these cutoffs were significant: PAINT (HR = 3.45), ISARIC4C (HR = 2.89), CHIS (HR = 4.02), and COVID-GRAM (HR = 3.15), highlighting the scores' abilities to predict severe outcomes. One week post symptom onset, these scores' predictive values and corresponding hazard ratios increased, further validating their prognostic significance over time. The evaluated COVID-19 prediction scores robustly predict mortality at admission and become more predictive by the seventh day of symptom onset. These findings support the use of these scores in clinical settings to facilitate early identification and intervention for high-risk patients, potentially improving patient outcomes during the ongoing global health crisis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tanase</LastName><ForeName>Alina Doina</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Professional Legislation in Dental Medicine, Faculty of Dental Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral School, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fnu</LastName><ForeName>Oktrian</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-4826-4625</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Indonesia, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cristescu</LastName><ForeName>Dan-Mihai</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Doctoral School, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Centre of Timisoara Institute of Cardiovascular Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barata</LastName><ForeName>Paula Irina</ForeName><Initials>PI</Initials><AffiliationInfo><Affiliation>Center for Research and Innovation in Precision Medicine of Respiratory Diseases, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology, Faculty of Medicine, "Vasile Goldis" Western University of Arad, 310025 Arad, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>David</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Discipline of Biochemistry, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrescu</LastName><ForeName>Emanuela-Lidia</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Department of Prostheses Technology and Dental Materials, Faculty of Dental Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Centre in Dental Medicine Using Conventional and Alternative Technologies, Faculty of Dental Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bojoga</LastName><ForeName>Daliana-Emanuela</ForeName><Initials>DE</Initials><Identifier Source="ORCID">0000-0002-8674-9973</Identifier><AffiliationInfo><Affiliation>Department of Oral Rehabilitation and Emergencies in Dental Medicine, Faculty of Dental Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdisciplinary Research Canter for Dental Medical Research, Lasers and Innovative Technologies Faculty of Dental Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoinoiu</LastName><ForeName>Teodora</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-7753-7621</Identifier><AffiliationInfo><Affiliation>Department of Clinical Practical Skills, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blidisel</LastName><ForeName>Alexandru</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6528-7733</Identifier><AffiliationInfo><Affiliation>Clinic of Surgical Semiotics and Thoracic Surgery-1, Department IX-Surgery-1, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Hepato-Biliary-Pancreatic Surgery (CHBP), "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pers Med</MedlineTA><NlmUniqueID>101602269</NlmUniqueID><ISSNLinking>2075-4426</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">prediction</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39338220</ArticleId><ArticleId IdType="pmc">PMC11433631</ArticleId><ArticleId IdType="doi">10.3390/jpm14090966</ArticleId><ArticleId IdType="pii">jpm14090966</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nguyen Q.D., Chang S.L., Jamerlan C.M., Prokopenko M. Measuring unequal distribution of pandemic severity across census years, variants of concern and interventions. Popul. Health Metr. 2023;21:17. doi: 10.1186/s12963-023-00318-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12963-023-00318-6</ArticleId><ArticleId IdType="pmc">PMC10613397</ArticleId><ArticleId IdType="pubmed">37899455</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma M., Shi L., Liu M., Yang J., Xie W., Sun G. Comparison of COVID-19 vaccine policies and their effectiveness in Korea, Japan, and Singapore. Int. J. Equity Health. 2023;22:224. doi: 10.1186/s12939-023-02034-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-023-02034-x</ArticleId><ArticleId IdType="pmc">PMC10588018</ArticleId><ArticleId IdType="pubmed">37864164</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboul-Fotouh S., Mahmoud A.N., Elnahas E.M., Habib M.Z., Abdelraouf S.M. What are the current anti-COVID-19 drugs? From traditional to smart molecular mechanisms. Virol. J. 2023;20:241. doi: 10.1186/s12985-023-02210-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-02210-z</ArticleId><ArticleId IdType="pmc">PMC10594888</ArticleId><ArticleId IdType="pubmed">37875904</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung H.F. The Virus, the Dollar, and the Global Order: The COVID-19 Crisis in Comparative Perspective. Dev. Chang. 2022 doi: 10.1111/dech.12735. ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dech.12735</ArticleId><ArticleId IdType="pmc">PMC9537930</ArticleId><ArticleId IdType="pubmed">36247352</ArticleId></ArticleIdList></Reference><Reference><Citation>Walmsley T., Rose A., John R., Wei D., Hlávka J.P., Machado J., Byrd K. Macroeconomic consequences of the COVID-19 pandemic. Econ. Model. 2023;120:106147. doi: 10.1016/j.econmod.2022.106147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.econmod.2022.106147</ArticleId><ArticleId IdType="pmc">PMC9768433</ArticleId><ArticleId IdType="pubmed">36570545</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose A. COVID-19 economic impacts in perspective: A comparison to recent U.S. disasters. Int. J. Disaster Risk Reduct. 2021;60:102317. doi: 10.1016/j.ijdrr.2021.102317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijdrr.2021.102317</ArticleId><ArticleId IdType="pmc">PMC9764161</ArticleId><ArticleId IdType="pubmed">36570630</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrick C. ‘We thank you for your sacrifice’: Clinical vulnerability, shielding and biosociality in the UK’s COVID-19 response. Biosocieties. 2023;18:218–240. doi: 10.1057/s41292-021-00266-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1057/s41292-021-00266-0</ArticleId><ArticleId IdType="pmc">PMC8783156</ArticleId><ArticleId IdType="pubmed">35096124</ArticleId></ArticleIdList></Reference><Reference><Citation>Kattan M.W., Ji X., Milinovich A., Adegboye J., Duggal A., Dweik R., Khouli H., Gordon S., Young J.B., Jehi L. An Algorithm for Classifying Patients Most Likely to Develop Severe Coronavirus Disease 2019 Illness. Crit. Care Explor. 2020;2:e0300. doi: 10.1097/CCE.0000000000000300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000300</ArticleId><ArticleId IdType="pmc">PMC7746202</ArticleId><ArticleId IdType="pubmed">33354674</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakeel S.M., Kumar N.S., Madalli P.P., Srinivasaiah R., Swamy D.R. COVID-19 prediction models: A systematic literature review. Osong Public Health Res. Perspect. 2021;12:215–229. doi: 10.24171/j.phrp.2021.0100.</Citation><ArticleIdList><ArticleId IdType="doi">10.24171/j.phrp.2021.0100</ArticleId><ArticleId IdType="pmc">PMC8408413</ArticleId><ArticleId IdType="pubmed">34465071</ArticleId></ArticleIdList></Reference><Reference><Citation>Weizman O., Duceau B., Trimaille A., Pommier T., Cellier J., Geneste L., Panagides V., Marsou W., Deney A., Attou S., et al. Machine learning-based scoring system to predict in-hospital outcomes in patients hospitalized with COVID-19. Arch. Cardiovasc. Dis. 2022;115:617–626. doi: 10.1016/j.acvd.2022.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acvd.2022.08.003</ArticleId><ArticleId IdType="pmc">PMC9595484</ArticleId><ArticleId IdType="pubmed">36376208</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayed M., Patel N., Angappan S., Nowak K., Vasconcelos Torres F., Penning D.H., Chhina A.K. Sequential Organ Failure Assessment (SOFA) Score and Mortality Prediction in Patients With Severe Respiratory Distress Secondary to COVID-19. Cureus. 2022;14:e26911. doi: 10.7759/cureus.26911.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.26911</ArticleId><ArticleId IdType="pmc">PMC9290429</ArticleId><ArticleId IdType="pubmed">35865183</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H., Cao T., Ji T., Luo Y., Huang J., Ma K. Predictive value of the neutrophil-to-lymphocyte ratio in the prognosis and risk of death for adult sepsis patients: A meta-analysis. Front. Immunol. 2024;15:1336456. doi: 10.3389/fimmu.2024.1336456.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1336456</ArticleId><ArticleId IdType="pmc">PMC10982325</ArticleId><ArticleId IdType="pubmed">38562922</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravindra R., Ramamurthy P., Aslam S.S.M., Kulkarni A., Suhail K., Ramamurthy P.S. Platelet Indices and Platelet to Lymphocyte Ratio (PLR) as Markers for Predicting COVID-19 Infection Severity. Cureus. 2022;14:e28206. doi: 10.7759/cureus.28206.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.28206</ArticleId><ArticleId IdType="pmc">PMC9484704</ArticleId><ArticleId IdType="pubmed">36158356</ArticleId></ArticleIdList></Reference><Reference><Citation>Carriel J., Muñoz-Jaramillo R., Bolaños-Ladinez O., Heredia-Villacreses F., Menéndez-Sanchón J., Martin-Delgado J., COVID-EC Researh Group CURB-65 as a predictor of 30-day mortality in patients hospitalized with COVID-19 in Ecuador: COVID-EC study. Rev. Clin. Esp. 2022;222:37–41. doi: 10.1016/j.rce.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rce.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC8086802</ArticleId><ArticleId IdType="pubmed">34996587</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Tiwari S., Deb M.K., Marty J.L. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): A global pandemic and treatment strategies. Int. J. Antimicrob. Agents. 2020;56:106054. doi: 10.1016/j.ijantimicag.2020.106054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106054</ArticleId><ArticleId IdType="pmc">PMC7286265</ArticleId><ArticleId IdType="pubmed">32534188</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Ramasamy A., Verduzco-Gutierrez M., Brode W.M., Melamed E. Acute and post-acute sequelae of SARS-CoV-2 infection: A review of risk factors and social determinants. Virol. J. 2023;20:124. doi: 10.1186/s12985-023-02061-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-02061-8</ArticleId><ArticleId IdType="pmc">PMC10276420</ArticleId><ArticleId IdType="pubmed">37328773</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Wu D., Liu C.H., Li Y., Hu J., Wang W., Jiang W., Zhang Q., Huang Z., Bai L., et al. Predicting progression to severe COVID-19 using the PAINT score. BMC Infect. Dis. 2022;22:498. doi: 10.1186/s12879-022-07466-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07466-4</ArticleId><ArticleId IdType="pmc">PMC9134988</ArticleId><ArticleId IdType="pubmed">35619076</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu Elhassan U.E., Alqahtani S.M.A., Al Saglan N.S., Hawan A., Alqahtani F.S., Almtheeb R.S., Abdelwahab M.S.R., AlFlan M.A., Alfaifi A.S.Y., Alqahtani M.A., et al. Utility of the 4C ISARIC mortality score in hospitalized COVID-19 patients at a large tertiary Saudi Arabian center. Multidiscip. Respir. Med. 2023;18:917. doi: 10.4081/mrm.2023.917.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/mrm.2023.917</ArticleId><ArticleId IdType="pmc">PMC10483479</ArticleId><ArticleId IdType="pubmed">37692055</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb B.J., Peltan I.D., Jensen P., Hoda D., Hunter B., Silver A., Starr N., Buckel W., Grisel N., Hummel E., et al. Clinical criteria for COVID-19-associated hyperinflammatory syndrome: A cohort study. Lancet Rheumatol. 2020;2:e754–e763. doi: 10.1016/S2665-9913(20)30343-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30343-X</ArticleId><ArticleId IdType="pmc">PMC7524533</ArticleId><ArticleId IdType="pubmed">33015645</ArticleId></ArticleIdList></Reference><Reference><Citation>Sebastian A., Madziarski M., Madej M., Proc K., Szymala-Pędzik M., Żórawska J., Gronek M., Morgiel E., Kujawa K., Skarupski M., et al. The Usefulness of the COVID-GRAM Score in Predicting the Outcomes of Study Population with COVID-19. Int. J. Environ. Res. Public Health. 2022;19:12537. doi: 10.3390/ijerph191912537.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912537</ArticleId><ArticleId IdType="pmc">PMC9566437</ArticleId><ArticleId IdType="pubmed">36231836</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji D., Zhang D., Xu J., Chen Z., Yang T., Zhao P., Chen G., Cheng G., Wang Y., Bi J., et al. Prediction for Progression Risk in Patients with COVID-19 Pneumonia: The CALL Score. Clin. Infect. Dis. 2020;71:1393–1399. doi: 10.1093/cid/ciaa414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa414</ArticleId><ArticleId IdType="pmc">PMC7184473</ArticleId><ArticleId IdType="pubmed">32271369</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallipuram T., Schwartz B.C., Yang S.S., Jayaraman D., Dial S. External validation of the ISARIC4C Mortality Score to predict in-hospital mortality among patients with COVID-19 in a Canadian intensive care unit: A single-centre historical cohort study. Can. J. Anaesth. 2023;70:1362–1370. doi: 10.1007/s12630-023-02512-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-023-02512-4</ArticleId><ArticleId IdType="pmc">PMC10247267</ArticleId><ArticleId IdType="pubmed">37286748</ArticleId></ArticleIdList></Reference><Reference><Citation>Durie M.L., Neto A.S., Burrell A.J.C., Cooper D.J., Udy A.A., SPRINT-SARI Australia Investigators ISARIC-4C Mortality Score overestimates risk of death due to COVID-19 in Australian ICU patients: A validation cohort study. Crit. Care Resusc. 2023;23:403–413. doi: 10.51893/2021.4.OA5.</Citation><ArticleIdList><ArticleId IdType="doi">10.51893/2021.4.OA5</ArticleId><ArticleId IdType="pmc">PMC10692605</ArticleId><ArticleId IdType="pubmed">38046684</ArticleId></ArticleIdList></Reference><Reference><Citation>Albai O., Frandes M., Sima A., Timar B., Vlad A., Timar R. Practical Applicability of the ISARIC-4C Score on Severity and Mortality due to SARS-CoV-2 Infection in Patients with Type 2 Diabetes. Medicina. 2022;58:848. doi: 10.3390/medicina58070848.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58070848</ArticleId><ArticleId IdType="pmc">PMC9318227</ArticleId><ArticleId IdType="pubmed">35888567</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vito A., Colpani A., Saderi L., Puci M., Zauli B., Meloni M.C., Fois M., Bitti A., Di Castri C., Fiore V., et al. Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? Life. 2023;13:183. doi: 10.3390/life13010183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13010183</ArticleId><ArticleId IdType="pmc">PMC9863404</ArticleId><ArticleId IdType="pubmed">36676132</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu T.Y., D’Silva K.M., Patel N.J., Wang J., Mueller A.A., Fu X., Prisco L., Martin L., Vanni K.M.M., Zaccardelli A., et al. Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: A retrospective, comparative cohort study. Lancet Rheumatol. 2021;3:e638–e647. doi: 10.1016/S2665-9913(21)00140-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00140-5</ArticleId><ArticleId IdType="pmc">PMC8163294</ArticleId><ArticleId IdType="pubmed">34095857</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildirim M., Halacli B., Yuce D., Gunegul Y., Ersoy E.O., Topeli A. Assessment of Admission COVID-19 Associated Hyperinflammation Syndrome Score in Critically-Ill COVID-19 Patients. J. Intensive Care Med. 2023;38:70–77. doi: 10.1177/08850666221131265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08850666221131265</ArticleId><ArticleId IdType="pmc">PMC9549159</ArticleId><ArticleId IdType="pubmed">36213939</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>